• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过两种DNA测序方法证实ERCC1基因存在多态性。

Demonstration of a polymorphism in the gene ERCC1 by two DNA sequencing methods.

作者信息

Yu J, Reed E, Mu C, Bostickbruton F

机构信息

NCI,MED OVARIAN CANC SECT,MED BRANCH,DEV THERAPEUT DEPT,DIV CLIN SCI,BETHESDA,MD 20892.

出版信息

Oncol Rep. 1997 Sep-Oct;4(5):905-7. doi: 10.3892/or.4.5.905.

DOI:10.3892/or.4.5.905
PMID:21590163
Abstract

New methodology is important to the advancement of biomedical science. We recently described a polymorphism within exon IV of the ERCC1 gene, which is associated with an approximate 50% decrease in codon usage in some biological systems. In this report we show that this polymorphism can be readily demonstrated by standard manual DNA sequencing, and by a recently developed methodology which relies on spectrophotometric principles. The major advantage of this new methodology is that several-fold more samples can be assessed per unit time, at reduced cost.

摘要

新方法对生物医学科学的进步至关重要。我们最近描述了ERCC1基因第四外显子内的一种多态性,在某些生物系统中,这种多态性与密码子使用频率下降约50%相关。在本报告中,我们表明这种多态性可以通过标准的手动DNA测序以及一种基于分光光度原理的最新开发方法轻松检测到。这种新方法的主要优点是,每单位时间可以评估的样本数量增加了几倍,成本却降低了。

相似文献

1
Demonstration of a polymorphism in the gene ERCC1 by two DNA sequencing methods.通过两种DNA测序方法证实ERCC1基因存在多态性。
Oncol Rep. 1997 Sep-Oct;4(5):905-7. doi: 10.3892/or.4.5.905.
2
Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.两种人卵巢癌细胞系(A2780/CP70和MCAS)的比较,这两种细胞系对铂的耐药性相同,但在ERCC1基因的第118密码子处存在差异。
Int J Oncol. 2000 Mar;16(3):555-60. doi: 10.3892/ijo.16.3.555.
3
ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.ERCC1基因多态性作为接受铂类化疗的晚期结直肠癌患者临床结局的预测指标。
Clin Adv Hematol Oncol. 2003 Mar;1(3):162-6.
4
ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy.ERCC1基因第118位密码子多态性是接受铂类化疗的胰腺癌患者的一种有用的预后标志物。
Int J Oncol. 2008 May;32(5):1091-6.
5
Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population.青藏高原人群中切除修复交叉互补组1密码子118多态性、微小核糖核酸及蛋白表达与晚期胃癌一线FOLFOX-4治疗临床结局的关系
J Cancer Res Ther. 2013 Jul-Sep;9(3):410-5. doi: 10.4103/0973-1482.119319.
6
ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.ERCC1基因第118位密码子多态性是晚期结直肠癌患者对奥沙利铂/5-氟尿嘧啶联合化疗肿瘤反应的预测因素。
Clin Cancer Res. 2005 Sep 1;11(17):6212-7. doi: 10.1158/1078-0432.CCR-04-2216.
7
The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.错配修复基因 ERCC1 和 XRCC1 多态性的联合检测可更好地预测转移性结直肠癌患者对奥沙利铂为基础的化疗的临床疗效。
Cancer Chemother Pharmacol. 2010 Aug;66(3):493-500. doi: 10.1007/s00280-009-1186-3. Epub 2009 Dec 4.
8
Association between ERCC1 Polymorphism and the Risk and Clinicopathological Features of Breast Cancer in Thai Women in the Lower Northeastern Region.泰国东北部低地地区女性ERCC1基因多态性与乳腺癌风险及临床病理特征的关联
Asian Pac J Cancer Prev. 2017 Nov 26;18(11):2999-3002. doi: 10.22034/APJCP.2017.18.11.2999.
9
Association of an ERCC1 polymorphism with adult-onset glioma.
Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):843-7.
10
Clinical utility of plasma Epstein-Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma.血浆 Epstein-Barr 病毒 DNA 和 ERCC1 单核苷酸多态性在鼻咽癌中的临床应用。
Cancer. 2015 Aug 15;121(16):2720-9. doi: 10.1002/cncr.29413. Epub 2015 May 6.

引用本文的文献

1
Nucleotide excision repair and anti-cancer chemotherapy.核苷酸切除修复与抗癌化疗。
Cytotechnology. 1998 Sep;27(1-3):187-201. doi: 10.1023/A:1008016922425.